aromasil has been researched along with Ovarian Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assi, T; El Rassy, E; Kattan, J; Kourie, HR; Moussa, T | 1 |
| Chekhun, VF; Grabovoy, AN; Lukyanova, NY; Svintsitsky, VS; Tarasova, TO; Tkalia, IG; Todor, IN; Vorobyova, LI | 1 |
| Grabovoy, AN; Svintsitsky, VS; Tarasova, TO; Tkalia, IG; Vorobyova, LI | 1 |
| Learman, LA | 1 |
| Hammersmith, KM; Nagra, PK; Nottage, JM; Rapuano, CJ; Turaka, K | 1 |
| Chen, D; Hackl, W; Ortmann, O; Treeck, O | 1 |
| Cunat, S; Daurès, JP; Katsaros, D; Maudelonde, T; Miller, WR; Pujol, P; Rabenoelina, F; Sasano, H | 1 |
7 other study(ies) available for aromasil and Ovarian Neoplasms
| Article | Year |
|---|---|
Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozole.
Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Everolimus; Female; Granulosa Cell Tumor; Humans; Letrozole; Middle Aged; Nitriles; Ovarian Neoplasms; Triazoles | 2017 |
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Animals; Antineoplastic Agents; Apoptosis; Aromatase Inhibitors; Ascites; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Female; Gonadotropin-Releasing Hormone; Immunoenzyme Techniques; Ovarian Neoplasms; Rats; Rats, Wistar; Triptorelin Pamoate; Tumor Cells, Cultured | 2014 |
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats.
Topics: Androstadienes; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Female; Ovarian Neoplasms; Ovary; Rats; Rats, Wistar; Triptorelin Pamoate; Vascular Endothelial Growth Factor A | 2015 |
What is new in primary care? Best articles from the past year.
Topics: Alzheimer Disease; Androstadienes; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Contraception; Dementia, Vascular; Diphosphonates; Estrogens, Conjugated (USP); Female; Femoral Fractures; Humans; Mass Screening; Ovarian Neoplasms; Pregnancy; Pregnancy in Diabetics; Primary Health Care; Randomized Controlled Trials as Topic; Smoking; Stroke | 2012 |
Dry eye syndrome in aromatase inhibitor users.
Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Blepharitis; Breast Neoplasms; Conjunctival Diseases; Dry Eye Syndromes; Female; Humans; Keratitis; Letrozole; Middle Aged; Nitriles; Ovarian Neoplasms; Retrospective Studies; Triazoles; Vision Disorders | 2013 |
Effects of a combination of exemestane and paclitaxel on human tumor cells in vitro.
Topics: Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Ovarian Neoplasms; Paclitaxel; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Aromatase expression in ovarian epithelial cancers.
Topics: Androstadienes; Aromatase; Aromatase Inhibitors; Cell Proliferation; Cysts; Epithelial Cells; Estrogen Receptor alpha; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lasers; Letrozole; Microdissection; Middle Aged; Neoplasms, Glandular and Epithelial; Nitriles; Ovarian Neoplasms; Ovary; Polymerase Chain Reaction; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 2005 |